Latest News

Live Nation’s stock sinks on a possible antitrust suit — but Wall Street analysts aren’t worried


Analysts believe there is room for the concert-industry giant to make concessions without significantly changing the way it does business.

Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.

Previous article

FTSE 100 Live: Stocks against the ropes as inflation comes in hot

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News